Labelled (e.g., Tagged With Radioactive Tracer, Fluorescent Marker, Intercalator, Etc.) Patents (Class 536/26.6)
  • Patent number: 7863058
    Abstract: Disclosed are methods of attaching biologically active compounds to a solid surface, comprising modifying the solid surface using triazine chloride and attaching the biologically active compound to the triazine moiety.
    Type: Grant
    Filed: February 2, 2009
    Date of Patent: January 4, 2011
    Assignee: Illumina, Inc.
    Inventors: Chanfeng Zhao, Igor Kozlov, Galina Steinberg-Tatman
  • Patent number: 7858320
    Abstract: A method for labeling biological molecules and synthetic molecules that contain a geminal diol, such as RNA, carbohydrates or glycoproteins, using a periodate sequestering agent is provided. Compositions and kits for use in the labeling method are also provided.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: December 28, 2010
    Assignee: BioVentures, Inc.
    Inventors: Elliott P. Dawson, Kristie E. Womble
  • Patent number: 7851159
    Abstract: It is intended to provide a method for detecting a target nucleic acid with a specific base sequence existing in a sample mixture with high specificity and sensitivity by utilizing the formation of a hybrid with a complementary strand as a detection principle, and a nucleic acid for the detection.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: December 14, 2010
    Assignee: Japan Science and Technology Agency
    Inventors: Kenzo Fujimoto, Yoshinaga Yoshimura, Shinzi Ogasawara
  • Patent number: 7851155
    Abstract: This invention pertains to the field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions.
    Type: Grant
    Filed: December 26, 2006
    Date of Patent: December 14, 2010
    Assignee: Boston Probes, Inc.
    Inventors: James M. Coull, Mark J. Fiandaca, Mark D. Kristjanson, Jens J. Hyldig-Nielsen, Theresa S. Creasey
  • Publication number: 20100311178
    Abstract: The invention provides a nucleotide or nucleoside having a base attached to a detectable label via a cleavable linker, characterised in that the cleavable linker contains a moiety selected from the group comprising: Formula (I) (wherein X is selected from the group comprising O, S, NH and NQ wherein Q is a C1-10 substituted or unsubstituted alkyl group, Y is selected from the group comprising O, S, NH and N(allyl). T is hydrogen or a C1-10 substituted or unsubstituted alkyl group and * indicates where the moiety is connected to the remainder of the nucleotide or nucleoside).
    Type: Application
    Filed: June 21, 2010
    Publication date: December 9, 2010
    Inventors: Xiaohai Liu, John Milton, Silke Ruediger
  • Patent number: 7847075
    Abstract: Within oligonucleotides, 2-azapurine and especially 2-azaadenine bases form specifically base pairs with guanine. This base pair is of analogous stability as an adenine-thymine but less stable than a guanine-cytosine base pair. Therefore, the incorporation of 2-azaadenine residues into oligonucleotides instead of cytosine leads specifically to hybridization complexes with nucleic acids with homogenous stability. This is useful for the adaptation of the stabilities of different oligonucleotide sequences in all kinds of hybridization techniques, for example in oligomer chip technology.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: December 7, 2010
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Frank Seela, Helmut Rosemeyer, Enno Schweinberger, Dieter Heindl, Frank Bergmann
  • Patent number: 7847076
    Abstract: An oligonucleotide probe is disclosed, the probe including an oligonucleotide, a fluorescer molecule attached to a first end of the oligonucleotide and a quencher molecule attached to the opposite end of the oligonucleotide. The probe is rendered impervious to digestion by the 5??3? exonuclease activity of a polymerase and the 5??3? extension of by a polymerase. The invention also includes methods for performing combined PCR amplification and hybridization probing, one such method including the steps of contacting a target nucleic acid sequence with PCR reagents and an oligonucleotide probe as described above, and subjecting these reagents to thermal cycling. One preferred refinement of the above method further includes the addition of a strand displacer to facilitate amplification.
    Type: Grant
    Filed: August 18, 2008
    Date of Patent: December 7, 2010
    Assignee: Life Technologies Corporation
    Inventor: Paul E. Mayrand
  • Patent number: 7842811
    Abstract: Cyanine dye compounds having a negatively charged substituent that are nucleic acid stains, particularly for fluorescent staining of DNA, including compounds having the formula wherein W forms one or two fused 5- or 6-membered aromatic rings, ? has a value of 0 or 1, n has a value of 0, or 1, X is O, S, or Se, and D is a pyridinium, or quinolinium moiety, provided that the compound has at least one negatively charged substituent.
    Type: Grant
    Filed: January 12, 2010
    Date of Patent: November 30, 2010
    Assignee: Life Technologies Corporation
    Inventors: Jason Dallwig, David Hagen, Shih-Jung Huang, Gerald Thomas, Stephen Yue
  • Publication number: 20100292457
    Abstract: The invention provides novel dye-labeled ribonucleotide analogs and methods for synthesizing those analogs. The compounds of the invention are especially useful for DNA sequencing by the polymerase chain reaction.
    Type: Application
    Filed: January 25, 2010
    Publication date: November 18, 2010
    Applicant: Applied Biosystems, LLC
    Inventors: Peter Virgil Fisher, Paolo Vatta, Shaheer H. Khan
  • Publication number: 20100290990
    Abstract: The present invention relates to a method for preparing a 2-fluoropurine marked with the radioisotope 18F comprising a fluorination step for a 2-nitropurine derivative. The present invention comprises a 2-fluoropurine derivative marked with the radioisotope 18F which can be obtained by or during a method according to the invention and its various uses.
    Type: Application
    Filed: December 23, 2008
    Publication date: November 18, 2010
    Inventors: Louisa Barre, Patrice Marchand
  • Patent number: 7833756
    Abstract: Dibenzorhodamine compounds having the structure are disclosed, including nitrogen- and aryl-substituted forms thereof. In addition, two intermediates useful for synthesizing such compounds are disclosed, a first intermediate having the structure including nitrogen- and aryl-substituted forms thereof, and a second intermediate having the structure including nitrogen- and aryl-substituted forms thereof, wherein substituents at positions C-14 to C18 taken separately are selected from the group consisting of hydrogen, chlorine, fluorine, lower alkyl, carboxylic acid, sulfonic acid, —CH2OH, alkoxy, phenoxy, linking group, and substituted forms thereof. The invention further includes energy transfer dyes comprising the dibenzorhodamine compounds, nucleosides labeled with the dibenzorhodamine compounds, and nucleic acid analysis methods employing the dibenzorhodamine compounds.
    Type: Grant
    Filed: July 8, 2008
    Date of Patent: November 16, 2010
    Assignee: Applied Biosystems, LLC
    Inventors: Scott C. Benson, Joe Y. L. Lam, Steven Michael Menchen
  • Publication number: 20100286386
    Abstract: Nucleotide analogues comprising a reactive hydrazide function (formula II) used as initial synthons for preparing compounds (formula I) capable of inducing mutations or capable of inhibiting a DNA polymerase or a kinase provided. Nucleic acids comprising the nucleotide and nucleoside analogues are also provided. Methods of using the compounds are also provided.
    Type: Application
    Filed: November 14, 2007
    Publication date: November 11, 2010
    Inventors: Philippe Marliere, Sylvie Pochet
  • Patent number: 7824863
    Abstract: In one aspect of the invention, a method is provided for end-labeling RNA (total RNA, mRNA, cRNA or fragmented RNA). In one aspect of the present invention, T4 RNA ligase is used to attach a 3?-labeled AMP or CMP donor to an RNA acceptor molecule. In another embodiment, a pyrophosphate molecule 3?-AppN-3?-linker-detectable moiety is used as donor molecule.
    Type: Grant
    Filed: October 22, 2008
    Date of Patent: November 2, 2010
    Assignee: Affymetrix, Inc.
    Inventors: Kyle B. Cole, Vivi Truong, Glenn H. McGall, Anthony D. Barone
  • Patent number: 7824887
    Abstract: Disclosed herein a reversible terminator nucleotides and methods of use.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: November 2, 2010
    Assignee: Applied Biosystems LLC
    Inventors: Linda Lee, Gerald Zon
  • Patent number: 7825237
    Abstract: Novel linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye are provided. These linkers facilitate the efficient transfer of energy between a donor and acceptor dye in an energy transfer dye. One of these linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye has the general structure R21Z1C(O)R22R28 where R21 is a C1-5 alkyl attached to the donor dye, C(O) is a carbonyl group, Z1 is either NH, sulfur or oxygen, R22 is a substituent which includes an alkene, diene, alkyne, a five and six membered ring having at least one unsaturated bond or a fused ring structure which is attached to the carbonyl carbon, and R28 includes a functional group which attaches the linker to the acceptor dye.
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: November 2, 2010
    Assignee: Applied Biosystems, LLC
    Inventors: Linda Lee, Sandra Spurgeon, Barnett Rosenblum
  • Patent number: 7820391
    Abstract: A method of detecting a target nucleic acid.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: October 26, 2010
    Assignee: Osmetech Molecular Diagnostics
    Inventor: Tao Chunlin
  • Patent number: 7816503
    Abstract: The invention is directed to modified guanine-containing nucleosides and nucleotides and uses thereof. More specifically, the invention relates to modified fluorescently labelled guanine-containing nucleosides and nucleotides which exhibit enhanced fluorophore intensity by virtue of reduced quenching effects.
    Type: Grant
    Filed: September 21, 2009
    Date of Patent: October 19, 2010
    Assignee: Illumina Cambridge Limited
    Inventors: John Milton, Xiaohai Liu
  • Patent number: 7816501
    Abstract: This invention is directed to compositions comprising a linked acceptor moiety.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: October 19, 2010
    Assignee: Boston Probes, Inc.
    Inventors: James M. Coull, Brian D. Gildea, Jens J. Hyldig-Nielsen
  • Patent number: 7811755
    Abstract: The invention relates to methods, articles and compositions for the detection and analysis of biomolecules in a sample. Provided assays include those determining the presence of a target biomolecule in a sample or its relative amount, or the assays may be quantitative or semi-quantitative. The methods can be performed in an array format on a substrate.
    Type: Grant
    Filed: January 10, 2006
    Date of Patent: October 12, 2010
    Assignee: The Regents of the University of California
    Inventors: Guillermo C. Bazan, Bin Liu
  • Patent number: 7803934
    Abstract: The present invention provides massively parallel oligonucleotide synthesis and purification for applications that utilize large collections of defined high-fidelity oligonucleotides (e.g., from about 101 to about 105 different sequences, generally between 25-160 bases in length).
    Type: Grant
    Filed: January 28, 2009
    Date of Patent: September 28, 2010
    Assignee: Affymetrix, Inc.
    Inventors: Glenn H. McGall, Robert G. Kuimelis
  • Patent number: 7803943
    Abstract: Methods of using dyes and associated technology are provided. A dye, such as a monomeric dye or a dimeric dye, may be used in a nucleic acid gel staining application and/or a nucleic acid detection application. Such a dye and a salt that comprises an anion that is associated with a strong acid and a cation that is associated with a strong base may be used in such an application. A dimeric dye, such as a dimeric dye capable of forming a hairpin-like structure, may be used to stain and/or detect nucleic acids via a release-on-demand mechanism. A dimeric dye having low background fluorescence in the absence of nucleic acids and high fluorescence in the presence of nucleic acids, upon binding therewith, may be used to stain and/or detect nucleic acids.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: September 28, 2010
    Assignee: Biotium, Inc.
    Inventors: Fei Mao, Wai-Yee Leung
  • Patent number: 7803936
    Abstract: The invention provides a novel method of labeling oligonucleotides, with reporter moieties, including but not limited to, quenchers, fluorophores, biotin, digoxigenin, peptides and proteins. In addition, this invention provides a method of detecting hybridization of oligonucleotides. This invention also provides novel azo quenchers having the general formula shown below. The invention further provides compositions comprising labeled oligonucleotides and solid supports. The invention also provides kits comprising at least one composition of the present invention.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: September 28, 2010
    Assignee: Integrated DNA Technologies, Inc.
    Inventors: Andrei Laikhter, Joseph A. Walder, Mark Behlke, Mikhail Podyminogin, Yawfui Yong
  • Patent number: 7799912
    Abstract: A bifunctional compound comprising a molecular unit (I) intercalating between nucleobases (B) of nucleic acids, an active molecular unit (AD) capable of emitting a detectable signal, and optionally a spacer unit, in which the active molecular unit (AD) is selected from amongst chemical entities having a structure such as to interact electronically with the intercalating molecular unit (I) in such a way that, during the reaction of oxidation, the reduction-oxidation potential (EI+/I) of the semicouple I+/I defined by the intercalating molecular unit (I) is lower than the reduction-oxidation potential (EB+/B) of the semicouple B+/B defined by the nucleobases (B), and in such a way that, during the reaction of reduction, the reduction-oxidation potential (EI/I?) of the semicouple I/I? defined by the intercalating molecular unit (I) is higher than the reduction-oxidation potential (EB/B?) of the semicouple B/B? defined by the nucleobases (B).
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: September 21, 2010
    Assignee: STMicroelectronics S.r.l.
    Inventors: Sabrina Conoci, Salvatore Sortino
  • Patent number: 7795042
    Abstract: The present invention provides novel, water-soluble, red-emitting fluorescent rhodamine dyes and red-emitting fluorescent energy-transfer dye pairs, as well as labeled conjugates comprising the same and methods for their use. The dyes, energy-transfer dye pairs and labeled conjugates are useful in a variety of aqueous-based applications, particularly in assays involving staining of cells, protein binding, and/or analysis of nucleic acids, such as hybridization assays and nucleic acid sequencing.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: September 14, 2010
    Assignee: Applied Biosystems, LLC
    Inventors: Linda G. Lee, Ronald J. Graham, William E. Werner, Elana Swartzman, Lily Lu
  • Patent number: 7795424
    Abstract: The invention provides a nucleotide or nucleoside having a base attached to a detectable label via a cleavable linker, characterized in that the cleavable linker contains a moiety selected from the group comprising: Formula (I) (wherein X is selected from the group comprising O, S, NH and NQ wherein Q is a C1-10 substituted or unsubstituted alkyl group, Y is selected from the group comprising O, S, NH and N(allyl). T is hydrogen or a C1-10 substituted or unsubstituted alkyl group and * indicates where the moiety is connected to the remainder of the nucleotide or nucleoside).
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: September 14, 2010
    Assignee: Illumina Cambridge Limited
    Inventors: Xiaohai Liu, John Milton, Silke Ruediger
  • Patent number: 7790869
    Abstract: This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide analogue after the nucleotide analogue is incorporated into a growing strand of DNA in a polymerase reaction. The invention also provides nucleotide analogues which comprise unique labels attached to the nucleotide analogue through a cleavable linker, and a cleavable chemical group to cap the —OH group at the 3?-position of the deoxyribose.
    Type: Grant
    Filed: June 5, 2007
    Date of Patent: September 7, 2010
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Jingyue Ju, Zengmin Li, John Robert Edwards, Yasuhiro Itagaki
  • Patent number: 7785796
    Abstract: Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: August 31, 2010
    Assignee: Illumina Cambridge Limited
    Inventors: Shankar Balasubramanian, Colin Barnes, Xiaohai Liu, John Milton
  • Patent number: 7777013
    Abstract: Labeled nucleotide analogs used in place of naturally occurring nucleoside triphosphates or other analogs in template directed nucleic acid synthesis reactions and other nucleic acid reactions, and various analyses based thereon, including DNA sequencing, single base identification, hybridization assays and others.
    Type: Grant
    Filed: May 15, 2008
    Date of Patent: August 17, 2010
    Assignee: Pacific Biosciences of California, Inc.
    Inventors: Yue Xu, Jeffrey Wegener, Arek Bibillo
  • Patent number: 7776567
    Abstract: Dimeric and trimeric nucleic acid dyes, and associated systems and methods are provided. Such a dye may form a hairpin-like structure that enables it to stain nucleic acids via a release-on-demand mechanism, for example. Such a dye may have low background fluorescence in the absence of nucleic acids and high fluorescence in the presence of nucleic acids, upon binding therewith, for example. A dye provided herein may be useful in a variety of applications, such as in DNA quantitation in real-time PCR, for example.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: August 17, 2010
    Assignees: Biotium, Inc., AlleLogic Biosciences Corporation
    Inventors: Fei Mao, Wai-Yee Leung, Xing Xin
  • Patent number: 7772384
    Abstract: Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: August 10, 2010
    Assignee: Illumina Cambridge Limited
    Inventors: Shankar Balasubramanian, Colin Barnes, Xiaohai Liu
  • Patent number: 7771973
    Abstract: The invention provides modified nucleotide or nucleoside molecule comprising a purine or pyrimidine base and a ribose or deoxyribose sugar moiety having a removable 3?-OH blocking group covalently attached thereto, such that the 3? carbon atom has attached a group of the structure —O—Z wherein Z is any of —C(R?)2-O—R?, —C(R?)2-N(R?)2, —C(R?)2-N(H)R?, —C(R?)2-S—R? and —C(R?)2-F, wherein each R? is or is part of a removable protecting group; each R? is independently a hydrogen atom, an alkyl, substituted alkyl, arylalkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocyclic, acyl, cyano, alkoxy, aryloxy, heteroaryloxy or amido group, or a detectable label attached through a linking group; or (R?)2 represents an alkylidene group of formula ?C(R??)2 wherein each R?? may be the same or different and is selected from the group comprising hydrogen and halogen atoms and alkyl groups; and wherein said molecule may be reacted to yield an intermediate in which each R? is exchanged for H or, where Z is —C(R?)2-F, the F is ex
    Type: Grant
    Filed: June 1, 2009
    Date of Patent: August 10, 2010
    Assignee: Illumina Cambridge Limited
    Inventors: John Milton, Xiaolin Wu, Mark Smith, Joseph Brennan, Colin Barnes, Xiaohai Liu, Silke Ruediger
  • Patent number: 7767805
    Abstract: The invention provides nucleotide analogs and methods of using them in sequencing reactions.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: August 3, 2010
    Assignee: Helicos Biosciences Corporation
    Inventor: Philip Richard Buzby
  • Patent number: 7759061
    Abstract: This disclosure provides novel reversibly terminated ribonucleotides which can be used as a reagent for DNA sequencing reactions. Methods of sequencing nucleic acids using the disclosed nucleotides are also provided.
    Type: Grant
    Filed: June 2, 2005
    Date of Patent: July 20, 2010
    Assignee: TwistDx, Inc.
    Inventors: Olaf Piepenburg, Derek L. Stemple, Niall A. Armes
  • Patent number: 7759470
    Abstract: The current invention restates substituted indole nucleosides as both terminal as well as internal building blocks of labeled oligonucleotide probes for the detection, analysis and quantitation of nucleic acids. The substituent comprises a linker and a detectable group or a linker and a reactive group for post synthesis coupling. These modified nucleosides grant access to a wide application area. These new substituted indole nucleosides can be used as labeling reagents for the facile preparation of e.g. optimized hybridization probes, Taqman-probes, or molecular beacon probes.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: July 20, 2010
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Dieter Heindl, Frank Bergmann, Hans-Peter Josel, Dirk Kessler, Gunter Lampert, Christian Weilke
  • Patent number: 7759469
    Abstract: The current invention restates substituted nitroindole nucleosides as both terminal as well as internal building blocks of labeled oligonucleotide probes for the detection, analysis and quantitation of nucleic acids. The substituent comprises a linker and a detectable group or a linker and a reactive group for post synthesis coupling. These modified nucleosides grant access to a wide application area. These new substituted nitroindole nucleosides can be used as labeling reagents for the facile preparation of, e.g., optimized hybridization probes, simple probes, TAQMAN-probes or molecular beacon probes.
    Type: Grant
    Filed: March 8, 2006
    Date of Patent: July 20, 2010
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Dieter Heindl, Thomas Froehlich, Heribert Maerz, Monika Seller
  • Publication number: 20100174058
    Abstract: Oligonucleotide probes containing two labels are provided and are useful in hybridization assays. The probes can also contain a minor groove binding group.
    Type: Application
    Filed: January 6, 2010
    Publication date: July 8, 2010
    Inventors: Michael W. Reed, Eugeny Alexander Lukhtanov, Alexander A. Gall, Robert O. Dempcy, Nicolaas M.J. Vermeulen
  • Patent number: 7745126
    Abstract: This invention pertains to the field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions.
    Type: Grant
    Filed: December 26, 2006
    Date of Patent: June 29, 2010
    Assignee: Boston Probes, Inc.
    Inventors: James M. Coull, Mark J. Fiandaca, Mark D. Kristjanson, Jens J. Hyldig-Nielsen, Theresa S. Creasey
  • Patent number: 7745614
    Abstract: A universal linker structure is provided, in which a functional group and activating leaving group are placed on a tether, allowing the placement of an electrophile at the end of any nucleic acid sequence. The electrophile on the tether can react with a second nucleic acid carrying a nucleophile when the two nucleic acids are hybridized near one another, resulting in release of the leaving group, and creation of a functional change. The linker can be designed to destabilize the ligation product without slowing the rate of reaction. This lowers product inhibition, and the target DNA or RNA can become a catalyst for isothermally generating multiple signals for detection. This enhanced signal is demonstrated in solution experiments and in solid supported assays. The universal linkers of the present invention are simple and inexpensive to prepare, and can be appended to any polynucleotide in automated steps on a standard DNA synthesizer.
    Type: Grant
    Filed: September 1, 2005
    Date of Patent: June 29, 2010
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Eric Todd Kool, Hiroshi Abe
  • Publication number: 20100155590
    Abstract: The invention relates to a labeled transition metal complex comprising a transition metal atom, a reactive moiety for allowing a chemical or biological entity to become attached to the transition metal atom, an inert tridentate moiety as a stabilizing bridge, and a marker. The invention also relates to a labeled chemical or biological entity comprising a chemical or biological entity which is attached to said labeled transition metal complex, to the use of said complex for creating a defined shift in the molecular mass of said entity in order to facilitate mass spectrometric analysis of said entity, to methods for rendering chemical or biological entities distinguishable by mass spectrometry as well as to methods for mass spectrometric analysis of the chemical or biological entities.
    Type: Application
    Filed: December 1, 2005
    Publication date: June 24, 2010
    Applicant: Kreatch Biotechnology B.V.
    Inventors: Marie Lacombe, Franciscus Johannes Opdam, Eduard Gerhard Talman, Jacky Theo Maria Veuskens
  • Patent number: 7741044
    Abstract: A method of making a set of labelled compounds by the use of a preferably particulate support, comprises dividing the support into lots, performing a different chemical reaction on each lot of the support, e.g. to couple a chemical moiety to that lot of the support, tagging a fraction of each lot of the support with a different label, and combining the said lots of the support. The steps are repeated several times, preferably to build up oligomer molecules carrying labels which identify the nature and position of a monomer unit of the oligomer, and which are releasable from the support. Preferred labels, which are releasable from the compounds by cleavage to provide charged groups for analysis by mass spectrometry, are groups of the trityl (trimethylphenyl) family. Also claimed are libraries of these labels and their use in assays and nucleic acid analysis methods.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: June 22, 2010
    Inventors: Edwin Mellor Southern, Mikhail Sergeevich Shchepinov, John Nicholas Housby, Alan Lewis Hamilton, John Kenneth Elder
  • Patent number: 7728128
    Abstract: The present invention concerns novel dibenzo[c,h][1,5]naphthyridine of formula (I) and their use as DNA probes, as well as the methods for marking DNA using the same.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: June 1, 2010
    Assignees: Institut National de la Sante et de la Recherche Medicate (INSERM), Institut Curie, Centre National de la Recherche Scientifique (C.N.R.S.), Commissariat a l'Energie Atomique
    Inventors: Andreï Popov, David Grierson, Jean-Claude Florent
  • Patent number: 7727716
    Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: June 1, 2010
    Assignee: Life Technologies Corporation
    Inventors: Matthew Paul Beaudet, W. Gregory Cox, Stephen Yue
  • Patent number: 7723038
    Abstract: Methods are provided for amplification and monitoring of oligonucleotide amplification in which a primer has an overlap with one or more bases of a detection probe.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: May 25, 2010
    Assignee: Elitech Holding B.V.
    Inventors: Walt Mahoney, Nicolaas M. J. Vermeulen, Irina Afonina
  • Patent number: 7718374
    Abstract: Methods and probes are provided for the analysis of target sequences having two or more polymorphisms wherein one of the polymorphisms is to be distinguished and another polymorphism is to be masked.
    Type: Grant
    Filed: January 28, 2008
    Date of Patent: May 18, 2010
    Assignee: Elitech Holding B.V.
    Inventors: Yevgeniy Belousov, Robert O. Dempcy, Sergey G. Lokhov, Alexei Vorobiev
  • Patent number: 7713698
    Abstract: This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide analogue after the nucleotide analogue is incorporated into a growing strand of DNA in a polymerase reaction. The invention also provides nucleotide analogues which comprise unique labels attached to the nucleotide analogue through a cleavable linker, and a cleavable chemical group to cap the —OH group at the 3?-position of the deoxyribose.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: May 11, 2010
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Jingyue Ju, Zengmin Li, John Robert Edwards, Yasuhiro Itagaki
  • Patent number: 7713694
    Abstract: A method of enhancing the fluorescence of and/or producing an increased Stokes' shift in a fluorescent dye comprising combining the dye with a base and/or a detergent is described. The method is suitable in chemical or biochemical techniques using fluorescent dyes, particularly techniques requiring staining or labeling of organic molecules, such as electrophoresis.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: May 11, 2010
    Assignee: Fluorotechnics Pty Limited
    Inventors: James Alexander Mackintosh, Duncan Adam Veal, Peter Helmuth Karuso, Daniel Richard Coghlan, Hung-Yoon Choi
  • Publication number: 20100092971
    Abstract: The present invention provides, for example, a labeling substance that allows the double helix structure of a nucleic acid to be detected effectively. The present invention provides a compound having a structure derived from mononucleoside or mononucleotide, with the structure being represented by the following formula (1), (1b), or (1c), a tautomer or stereoisomer thereof, or a salt thereof. In the above formulae, B is an atomic group having a nucleobase skeleton, E is an atomic group having a deoxyribose skeleton, a ribose skeleton, or a structure derived from either one of them, or an atomic group having a peptide structure or a peptoid structure, and Z11 and Z12 each are a hydrogen atom, a protecting group, or an atomic group that exhibits fluorescence and may be identical to or different from each other.
    Type: Application
    Filed: March 6, 2008
    Publication date: April 15, 2010
    Applicant: RIKEN
    Inventors: Akimitsu Okamoto, Shuji Ikeda, Takeshi Kubota
  • Publication number: 20100093990
    Abstract: Described are modified mononucleotides and processes for their production wherein these nucleotides contain at least once the structure P?N-Acc in which Acc is an electron acceptor or an electron acceptor substituted with a residue R, and R is any organic substituent.
    Type: Application
    Filed: October 16, 2009
    Publication date: April 15, 2010
    Inventor: Dieter Heindl
  • Patent number: 7687618
    Abstract: The present invention relates to a method for the manufacture of labeled oligonucleotide conjugates comprising the reaction of (a) an oligonucleotide having a labile protecting group bound to a terminal hydroxy group, and (b) a labeling compound, wherein said labile protecting group is partially or completely substituted by said labeling compound in a nucleophilic substitution reaction.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: March 30, 2010
    Assignee: NIMBLEGEN SYSTEMS GmbH
    Inventors: Klaus Peter Stengele, Evgueni Kvassiouk
  • Patent number: 7683164
    Abstract: A compound which comprises a backbone having a plurality of chiral carbon atoms, the backbone bearing a plurality of ligands each being individually bound to a chiral carbon atom of the plurality of chiral carbon atoms, the ligands including one or more pair(s) of adjacent ligands each containing a moiety selected from the group consisting of a naturally occurring nucleobase and a nucleobase binding group, wherein moieties of the one or more pair(s) are directly linked to one another via a linker chain; building blocks for synthesizing the compound; and uses of the compound, particularly in antisense therapy.
    Type: Grant
    Filed: February 19, 2008
    Date of Patent: March 23, 2010
    Assignee: Bio-Rad Laboratories Inc.
    Inventor: David Segev